I bot many in 8s this morning. By the end of Feb, it is expected to reach 20.

 

RUNUP HAS JUST BEGUN ........ENJOY THE RIDE TO 20$++


With a market value of $96 million, Anika Therapeutics (ANIK) is a hidden growth story in the biotech arena .ANIK has been profitable for each of the past seven years.

2011 Price Target: $25.00+ .Buy with both hands now and you will make a lot of money with the upcoming FDA approvals .Get in now before the stock gets discovered.GLTA


Anika Therapeutics (ANIK)

Market-Cap: 96 Mil
Cash: 26 Mil
Price: 7.20

Shares Out: 13.5



UPCOMING MILESTONES :

Monovisc (osteoarthritis) (PMA) FDA approval in 1Q 2011 << Blockbuster Potential

Hyaloglide 510(K) expected FDA approval 1Q 2011

Hyalonect 510(K) expected FDA approval 1Q 2011

Hyalofast 510(K) expected FDA approval 1Q 2011